DiscoverCAG PodcastEpisode 41: Case Study 8: Maximizing Therapeutic Outcomes in an Evolving IBD Landscape
Episode 41: Case Study 8: Maximizing Therapeutic Outcomes in an Evolving IBD Landscape

Episode 41: Case Study 8: Maximizing Therapeutic Outcomes in an Evolving IBD Landscape

Update: 2021-04-10
Share

Description

Learning Objectives:

1. Recognize inadequate response to induction and/or secondary loss of response quickly and optimize therapy accordingly

2. Consider the risks and benefits of combination therapy with immunomodulatory

3. Describe which patients may benefit from biologic monotherapy

Download Now
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 41: Case Study 8: Maximizing Therapeutic Outcomes in an Evolving IBD Landscape

Episode 41: Case Study 8: Maximizing Therapeutic Outcomes in an Evolving IBD Landscape

The Canadian Association of Gastroenterology - Dr. Remo Panaccione, University of Calgary and Dr. Waqqas Afif, McGill University